Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases.
Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease.
Company Details
- Founded
- 2015
- Address
- 953 Indiana Street, San Francisco,california (Ca) 94107,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://deliniabio.com
- Keywords
- Atlas Venture.
- HQ
- San Francisco, California (CA)
Delinia Questions
Delinia's website is http://deliniabio.com
Delinia's LinkedIn profile is https://www.linkedin.com/company/delinia
Delinia's industry is
Biotechnology Research
Delinia's top competitors are
Cyberark,
Delini,
Dilinea,
Rapid7,
Vivid Biosciences,
Delinian,
Synlogic,
Delinea,
Ge Vernova,
Atlas Venture.
Delinia's categories are Biotechnology Research
Delinia's founding year is 2015
